Browse > Article
http://dx.doi.org/10.7742/jksr.2012.6.6.507

A Research on Superparamagnetic Iron Oxide Nanoparticles' Toxicity to U373MG Cell and its Effect on the Radiation Survival Curve  

Kang, Seonghee (Department of Radiological Science, College of Medical Science, Konyang University)
Kim, Jeonghwan (Department of Anatomy, College of Medicine, Konyang University)
Kim, Dokyung (Industry Cooperation Foundation, Konyang University)
Kang, Bosun (Department of Radiological Science, College of Medical Science, Konyang University)
Publication Information
Journal of the Korean Society of Radiology / v.6, no.6, 2012 , pp. 507-513 More about this Journal
Abstract
This research was performed to evaluate the superparamagnetic iron oxide nanoparticles'(SPIONs) cell toxicity and to measure the radiation cell survival curve changes of SPIONs-uptake glioblastoma multiforme cells. The results could be practically used as the fundamental data to ameliorate proton beam cancer therapy, for example, providing necessary GBM treatment dose in the proton beam therapy when the therapy takes advantage of SPIONs. The assessment of the toxicological evaluation of synthesized SPIONs was accomplished by MTT assay as an in vitro experiment. The results showed no meaningful differences in the cell survival rate at the $1-100{\mu}g/ml$ SPIONs concentrations, but the cell toxicity was shown as the cell survival rate decreased up to 74.2% at the $200{\mu}g/ml$ SPIONs concentration. Then, we measured each radiation cell survival curve for U373MG cells and SPIONs-uptake U373MG cells with 0~5 Gy of proton beam irradiations. It is learned from the analysis of the experimental results that the SPION-uptake cells' radiation survival rate was more rapidly decreased as the irradiation dose increased. In conclusion we confirmed that SPIONs-uptake in U373MG cells induces cell death at the much less dose than the lethal dose of SPION-non-uptake cell. This research shows that the therapeutic efficacy of glioblastoma multiforme treatment in proton beam therapy can be improved by SPIONs targeting to the GBM cells.
Keywords
Proton beam; GBM; Cell toxicological evaluation; MTT assay; Cell survival curve; U373MG cell; Superparmagnetic Iron Oxide Nanoparticles; SPIONs;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Barbara Alicja jereczek-Fossa MD, PhD Marco Krengli MD, Roberto Orecchia MD, "Particle beam radiotherapy for head and neck tumors: Radiobiological basis and clinical experience", HEAD&NECK, Vol. 28, pp.750-760, 2006
2 Paola Scampoli, "Biological effects of accelerated protons", Heavy Charged Particles in Biology and Medecine, Vol. 73, pp.S130-S133, 2004.
3 김대용, 박성용, Proton Beam Therapy, 대한의사협회지, Vol. 51, No. 7, pp.638-642, 2008.
4 Xuan Phuc Nguyen, ""Iron oxide-based conjugates for cancer theragnostics"", IOP Science, Vol. 3, pp.13, 2012.
5 Van Meir, E. G.; Hadjipanayis, C. G.; Norden, A. D.; Shu, H. K.; Wen, P. Y.; Olson, J. J. "Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma". CA: A Cancer Journal for Clinicians Vol. 60, No. 3, pp. 166-193, 2010   DOI   ScienceOn
6 W.Rueter, A.Lurio, E.Cardone and J.F.Ziegler, J. of Applied Physics, Vol. 46, pp.3194, 1975.   DOI   ScienceOn
7 Jong-Ki Kim, Seung-Jin Seo, Ki-Hong Kim, Tae-Jeong Kim, Myung-Hwan Chung, Kye-Ryung Kim, and Tae-Keun Yang, "Therapeutic application of metallic nanoparticles combined with particle-induced x-ray emission effect", Nanotechnology Vol. 21 pp.425102-425112, 2010   DOI   ScienceOn
8 Berridge MV, Tan As, "Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction", Archives of Biochemistry and Biophysics, Vol. 303, pp.474-482, 1993.   DOI   ScienceOn
9 http://mc50.kirams.re.kr
10 JM Hillegass, "Assessing nanotoxicity in cells in vitro", Wiley Interdiscip Rev Nanomed Nanobiotechnol, Vol. 2, pp.219-231, 2010.   DOI
11 KM Prise, G Schettino, M Folkard, KD Held, "New insights on cell death from radiation exposure", The Lancet Oncology, Vol. 6, pp.520-528, 2005   DOI   ScienceOn